LONG COVID19

Clinical trials for LONG COVID19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID19 trials appear

Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2 Completed 8

Could a new drug tame the immune chaos of long COVID POTS?

Symptom relief Recruiting now

This study tests whether a drug called 2-HOBA can reduce immune system overactivity in people with Long COVID-related POTS, a condition causing rapid heart rate, fatigue, and dizziness. Researchers will give 50 participants either 2-HOBA or a placebo for 28 days to see if it lowe…

Matched conditions: LONG COVID19

Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief

Last updated Jun 01, 2026 18:04 UTC

LONG COVID19

Get alerted when new LONG COVID19 trials appear

Could a new drug tame the immune chaos of long COVID POTS?